Search

The asymmetric unit of the title co-crystal, C12H9N5O·C7H6O3, contains one molecule of N6-benzoyladenine (BA) and one molecule of 4-hydroxybenzoic acid (HBA). The N6-benzoyladenine (BA) has an N(7)--H tautomeric form with nonprotonated N-1 and N-3 atoms. This tautomeric form is stabilized by a typical intramolecular N--H⋯O hydrogen bond between the carbonyl (C＝O) group and the N(7)--H hydrogen on the Hoogsteen face of the purine ring, forming a graph-set S(7) ring motif. The primary robust R²2(8) ring motif is formed in the Watson-Crick face via N--H⋯O and O--H⋯N hydrogen bonds (involving N1, N6--H and the carboxyl group of HBA).Weak interactions, such as, C--H⋯π and π-π are also observed in this crystal structure. [ABSTRACT FROM AUTHOR]

The asymmetric unit of the title co-crystal, C12H9N5O0.5C6H10O4, consists of one molecule of N6-benzoyladenine (BA) and one half-molecule of adipic acid (AA), the other half being generated by inversion symmetry. The dihedral angle between the adenine and phenyl ring planes is 26.71 (7)°. The N6-benzoyladenine molecule crystallizes in the N(7)--H tautomeric form with three non-pro tonated N atoms. This tautomeric form is stabilized by intramolecular N--H⋯O hydrogen bonding between the carbonyl (CO) group and the N(7)--H hydrogen atom on the Hoogsteen face of the purine ring, forming an S(7) ring motif. The two carboxyl groups of adipic acid interact with the Watson-Crick face of the BA molecules through O--H⋯N and N--H⋯O hydrogen bonds, generating an R2²(8) ring motif. The latter units are linked by N--H⋯N hydrogen bonds, forming layers parallel to (105. A weak C--H⋯O hydrogen bond is also present, linking adipic acid molecules in neighbouring layers, enclosing R²2(10) ring motifs and forming a three-dimensional structure. C=O⋯π and C--H⋯π interactions are also present in the structure. [ABSTRACT FROM AUTHOR]